Malignant :: how bad policy and bad evidence harm people with cancer /
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) detai...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Baltimore :
Johns Hopkins University Press,
2020.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"-- |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 1421437643 9781421437644 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1151401571 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 190702t20202020mdu ob 001 0 eng d | ||
| 040 | |a P@U |b eng |e rda |e pn |c P@U |d OCLCO |d YDX |d EBLCP |d YDXIT |d N$T |d TEFOD |d UX1 |d OCLCF |d TOH |d OCLCO |d UKAHL |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d K6U |d OCLCO |d OCLCQ |d CASUM |d OCLCO |d OCLCL | ||
| 020 | |a 1421437643 |q (electronic book) | ||
| 020 | |a 9781421437644 |q (electronic bk.) | ||
| 020 | |z 9781421437637 | ||
| 020 | |z 1421437635 | ||
| 035 | |a (OCoLC)1151401571 | ||
| 037 | |a FABAFD0F-903E-4ECB-9C52-3E97128B2D2B |b OverDrive, Inc. |n http://www.overdrive.com | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RC271.C5 |b P73 2020 | |
| 060 | 4 | |a QZ 266 | |
| 082 | 7 | |a 616.99/4061 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Prasad, Vinayak K., |d 1982- |e author. |0 http://id.loc.gov/authorities/names/n2015180130 | |
| 245 | 1 | 0 | |a Malignant : |b how bad policy and bad evidence harm people with cancer / |c Vinayak K. Prasad. |
| 246 | 3 | 0 | |a How bad policy and bad evidence harm people with cancer |
| 264 | 1 | |a Baltimore : |b Johns Hopkins University Press, |c 2020. | |
| 264 | 4 | |c ©2020 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do? | |
| 520 | |a "In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"-- |c Provided by publisher | ||
| 588 | 0 | |a Online resource; title from digital title page (viewed on April 27, 2020). | |
| 650 | 0 | |a Cancer |x Chemotherapy |z United States. | |
| 650 | 0 | |a Antineoplastic agents |x Economic aspects |z United States. | |
| 650 | 0 | |a Medicine |x Research |x Economic aspects |z United States. | |
| 650 | 0 | |a Drug development |x Economic aspects |z United States. | |
| 650 | 0 | |a Medical policy |z United States. | |
| 650 | 0 | |a Patients |x Civil rights |z United States. | |
| 650 | 0 | |a Medical policy. |0 http://id.loc.gov/authorities/subjects/sh85083002 | |
| 650 | 1 | 2 | |a Neoplasms |x drug therapy |0 https://id.nlm.nih.gov/mesh/D009369Q000188 |
| 650 | 2 | 2 | |a Antineoplastic Agents |x economics |0 https://id.nlm.nih.gov/mesh/D000970Q000191 |
| 650 | 2 | 2 | |a Biomedical Research |x economics |0 https://id.nlm.nih.gov/mesh/D035843Q000191 |
| 650 | 2 | 2 | |a Drug Development |x economics |
| 650 | 2 | 2 | |a Health Policy |
| 650 | 2 | 2 | |a Patient Rights |
| 651 | 2 | |a United States |0 https://id.nlm.nih.gov/mesh/D014481 | |
| 650 | 6 | |a Cancer |x Chimiothérapie |z États-Unis. | |
| 650 | 6 | |a Anticancéreux |x Aspect économique |z États-Unis. | |
| 650 | 6 | |a Médecine |x Recherche |x Aspect économique |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Développement |x Aspect économique |z États-Unis. | |
| 650 | 6 | |a Politique sanitaire |z États-Unis. | |
| 650 | 6 | |a Patients |x Droits |z États-Unis. | |
| 650 | 6 | |a Politique sanitaire. | |
| 650 | 7 | |a Cancer |x Chemotherapy |2 fast | |
| 650 | 7 | |a Medical policy |2 fast | |
| 650 | 7 | |a Medicine |x Research |x Economic aspects |2 fast | |
| 650 | 7 | |a Patients |x Civil rights |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 4 | |a Internet Resources. | |
| 758 | |i has work: |a Malignant (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFQHfq74jjHbGp7BWm3XwK |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Prasad, Vinayak K., 1982- |t Malignant. |d Baltimore : Johns Hopkins University Press, 2020 |w (DLC) 2019027982 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266298 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36704566 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6181189 | ||
| 938 | |a EBSCOhost |b EBSC |n 2266298 | ||
| 938 | |a Project MUSE |b MUSE |n muse81823 | ||
| 938 | |a YBP Library Services |b YANK |n 16735924 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1151401571 |
|---|---|
| _version_ | 1816882515803111424 |
| adam_text | |
| any_adam_object | |
| author | Prasad, Vinayak K., 1982- |
| author_GND | http://id.loc.gov/authorities/names/n2015180130 |
| author_facet | Prasad, Vinayak K., 1982- |
| author_role | aut |
| author_sort | Prasad, Vinayak K., 1982- |
| author_variant | v k p vk vkp |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 P73 2020 |
| callnumber-search | RC271.C5 P73 2020 |
| callnumber-sort | RC 3271 C5 P73 42020 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do? |
| ctrlnum | (OCoLC)1151401571 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05070cam a2200829 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1151401571</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">190702t20202020mdu ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">P@U</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">P@U</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDX</subfield><subfield code="d">EBLCP</subfield><subfield code="d">YDXIT</subfield><subfield code="d">N$T</subfield><subfield code="d">TEFOD</subfield><subfield code="d">UX1</subfield><subfield code="d">OCLCF</subfield><subfield code="d">TOH</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CASUM</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1421437643</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781421437644</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781421437637</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1421437635</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1151401571</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">FABAFD0F-903E-4ECB-9C52-3E97128B2D2B</subfield><subfield code="b">OverDrive, Inc.</subfield><subfield code="n">http://www.overdrive.com</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC271.C5</subfield><subfield code="b">P73 2020</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QZ 266</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Prasad, Vinayak K.,</subfield><subfield code="d">1982-</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2015180130</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Malignant :</subfield><subfield code="b">how bad policy and bad evidence harm people with cancer /</subfield><subfield code="c">Vinayak K. Prasad.</subfield></datafield><datafield tag="246" ind1="3" ind2="0"><subfield code="a">How bad policy and bad evidence harm people with cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Baltimore :</subfield><subfield code="b">Johns Hopkins University Press,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do?</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"--</subfield><subfield code="c">Provided by publisher</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from digital title page (viewed on April 27, 2020).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug development</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Patients</subfield><subfield code="x">Civil rights</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85083002</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009369Q000188</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">economics</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000970Q000191</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Biomedical Research</subfield><subfield code="x">economics</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D035843Q000191</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Development</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Policy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Patient Rights</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014481</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Chimiothérapie</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Anticancéreux</subfield><subfield code="x">Aspect économique</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine</subfield><subfield code="x">Recherche</subfield><subfield code="x">Aspect économique</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Développement</subfield><subfield code="x">Aspect économique</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Patients</subfield><subfield code="x">Droits</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patients</subfield><subfield code="x">Civil rights</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Internet Resources.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Malignant (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFQHfq74jjHbGp7BWm3XwK</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Prasad, Vinayak K., 1982-</subfield><subfield code="t">Malignant.</subfield><subfield code="d">Baltimore : Johns Hopkins University Press, 2020</subfield><subfield code="w">(DLC) 2019027982</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266298</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36704566</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6181189</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2266298</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Project MUSE</subfield><subfield code="b">MUSE</subfield><subfield code="n">muse81823</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">16735924</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Internet Resources. |
| genre_facet | Internet Resources. |
| geographic | United States https://id.nlm.nih.gov/mesh/D014481 United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-on1151401571 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:29:51Z |
| institution | BVB |
| isbn | 1421437643 9781421437644 |
| language | English |
| oclc_num | 1151401571 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Johns Hopkins University Press, |
| record_format | marc |
| spelling | Prasad, Vinayak K., 1982- author. http://id.loc.gov/authorities/names/n2015180130 Malignant : how bad policy and bad evidence harm people with cancer / Vinayak K. Prasad. How bad policy and bad evidence harm people with cancer Baltimore : Johns Hopkins University Press, 2020. ©2020 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do? "In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"-- Provided by publisher Online resource; title from digital title page (viewed on April 27, 2020). Cancer Chemotherapy United States. Antineoplastic agents Economic aspects United States. Medicine Research Economic aspects United States. Drug development Economic aspects United States. Medical policy United States. Patients Civil rights United States. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Neoplasms drug therapy https://id.nlm.nih.gov/mesh/D009369Q000188 Antineoplastic Agents economics https://id.nlm.nih.gov/mesh/D000970Q000191 Biomedical Research economics https://id.nlm.nih.gov/mesh/D035843Q000191 Drug Development economics Health Policy Patient Rights United States https://id.nlm.nih.gov/mesh/D014481 Cancer Chimiothérapie États-Unis. Anticancéreux Aspect économique États-Unis. Médecine Recherche Aspect économique États-Unis. Médicaments Développement Aspect économique États-Unis. Politique sanitaire États-Unis. Patients Droits États-Unis. Politique sanitaire. Cancer Chemotherapy fast Medical policy fast Medicine Research Economic aspects fast Patients Civil rights fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Internet Resources. has work: Malignant (Text) https://id.oclc.org/worldcat/entity/E39PCFQHfq74jjHbGp7BWm3XwK https://id.oclc.org/worldcat/ontology/hasWork Print version: Prasad, Vinayak K., 1982- Malignant. Baltimore : Johns Hopkins University Press, 2020 (DLC) 2019027982 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266298 Volltext |
| spellingShingle | Prasad, Vinayak K., 1982- Malignant : how bad policy and bad evidence harm people with cancer / The Basics of Cancer Drugs : Cost, Benefit, Value -- Surrogate Endpoints in Cancer : What Are They and Where Are They Used? -- Use and Misuse of Surrogates for Drug Approvals -- How High Prices Harm Patients and Society -- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine -- Financial Conflict of Interest -- The Harms of Financial Conflicts and How to Rehabilitate Medicine -- Will Precision Oncology Save Us? -- Study Design -- Principles of Oncology Practice -- Important Trials in Oncology -- Global Oncology -- How Should Cancer Drug Development Proceed? -- What Can the US Food and Drug Administration and the Centers for Medicare and -- Medicaid Services Do Tomorrow? -- What Can People with Cancer Do? -- What Can Students, Residents, and Fellows Do? Cancer Chemotherapy United States. Antineoplastic agents Economic aspects United States. Medicine Research Economic aspects United States. Drug development Economic aspects United States. Medical policy United States. Patients Civil rights United States. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Neoplasms drug therapy https://id.nlm.nih.gov/mesh/D009369Q000188 Antineoplastic Agents economics https://id.nlm.nih.gov/mesh/D000970Q000191 Biomedical Research economics https://id.nlm.nih.gov/mesh/D035843Q000191 Drug Development economics Health Policy Patient Rights Cancer Chimiothérapie États-Unis. Anticancéreux Aspect économique États-Unis. Médecine Recherche Aspect économique États-Unis. Médicaments Développement Aspect économique États-Unis. Politique sanitaire États-Unis. Patients Droits États-Unis. Politique sanitaire. Cancer Chemotherapy fast Medical policy fast Medicine Research Economic aspects fast Patients Civil rights fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85083002 https://id.nlm.nih.gov/mesh/D009369Q000188 https://id.nlm.nih.gov/mesh/D000970Q000191 https://id.nlm.nih.gov/mesh/D035843Q000191 https://id.nlm.nih.gov/mesh/D014481 |
| title | Malignant : how bad policy and bad evidence harm people with cancer / |
| title_alt | How bad policy and bad evidence harm people with cancer |
| title_auth | Malignant : how bad policy and bad evidence harm people with cancer / |
| title_exact_search | Malignant : how bad policy and bad evidence harm people with cancer / |
| title_full | Malignant : how bad policy and bad evidence harm people with cancer / Vinayak K. Prasad. |
| title_fullStr | Malignant : how bad policy and bad evidence harm people with cancer / Vinayak K. Prasad. |
| title_full_unstemmed | Malignant : how bad policy and bad evidence harm people with cancer / Vinayak K. Prasad. |
| title_short | Malignant : |
| title_sort | malignant how bad policy and bad evidence harm people with cancer |
| title_sub | how bad policy and bad evidence harm people with cancer / |
| topic | Cancer Chemotherapy United States. Antineoplastic agents Economic aspects United States. Medicine Research Economic aspects United States. Drug development Economic aspects United States. Medical policy United States. Patients Civil rights United States. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Neoplasms drug therapy https://id.nlm.nih.gov/mesh/D009369Q000188 Antineoplastic Agents economics https://id.nlm.nih.gov/mesh/D000970Q000191 Biomedical Research economics https://id.nlm.nih.gov/mesh/D035843Q000191 Drug Development economics Health Policy Patient Rights Cancer Chimiothérapie États-Unis. Anticancéreux Aspect économique États-Unis. Médecine Recherche Aspect économique États-Unis. Médicaments Développement Aspect économique États-Unis. Politique sanitaire États-Unis. Patients Droits États-Unis. Politique sanitaire. Cancer Chemotherapy fast Medical policy fast Medicine Research Economic aspects fast Patients Civil rights fast |
| topic_facet | Cancer Chemotherapy United States. Antineoplastic agents Economic aspects United States. Medicine Research Economic aspects United States. Drug development Economic aspects United States. Medical policy United States. Patients Civil rights United States. Medical policy. Neoplasms drug therapy Antineoplastic Agents economics Biomedical Research economics Drug Development economics Health Policy Patient Rights United States Cancer Chimiothérapie États-Unis. Anticancéreux Aspect économique États-Unis. Médecine Recherche Aspect économique États-Unis. Médicaments Développement Aspect économique États-Unis. Politique sanitaire États-Unis. Patients Droits États-Unis. Politique sanitaire. Cancer Chemotherapy Medical policy Medicine Research Economic aspects Patients Civil rights Internet Resources. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266298 |
| work_keys_str_mv | AT prasadvinayakk malignanthowbadpolicyandbadevidenceharmpeoplewithcancer AT prasadvinayakk howbadpolicyandbadevidenceharmpeoplewithcancer |